Heterotropic activation

The architecture of various CYPs may accommodate entities of different shapes [139]. Several CYPs, particularly CYP3A4 [140,141] and CYP2C9 [142], may exhibit atypical (non-Michaelis-Menten) kinetics such as heterotropic activation, homotropic activation, substrate inhibition and partial inhibition, all in a substrate-effector-dependent manner [143]. Several hypotheses have been proposed to account for the observation of atypical kinetics, including simultaneous occupancy of the CYP active site by two substrates (or one substrate and one effector simultaneously) [144] and allosteric changes in CYP architecture due to binding of an effector [145,146]. Along... 

Ladd, T.I., R.M. Ventullo, P.M. Wallis, and J.W. Costerton. 1982. Heterotropic activity and biodegradation of labile and refractory compounds in groundwater and stream microbial populations. Appl. Environ. Microbiol. 44 321-329. 

In addition to being prone to homotropic activation, CYP3A4 is also prone to heterotropic activation. The CYP1A2 inhibitor, a-naphthoflavone is an activator of certain CYP3A4-dependent reactions [a factor that complicates the use of this flavonoid in CYP inhibition studies (discussed later)]. CYP3A4-catalyzed... 

Heterotropic Activation In the case of heterotropic activation, the addition of another compound to the incubation mixture results in an increased velocity for substrate turnover without increasing the amount of enzyme present. This result is in contrast to the inhibition interaction that is typically expected when two substrates are coincubated. Again, this... 

An allosteric situation where is constant but the apparent changes in response to effectors is termed a V system. In a V system, all v versus S plots are hyperbolic rather than sigmoid (Figure 15.12). The positive heterotropic effector A activates by raising whereas 1, the negative heterotropic effec-... 

Heterotropic (nonsubstrate) activators bind to and stabilize the R state, while heterotropic inhibitors bind preferentially to the T state. 

When binding of a substrate molecule at an enzyme active site promotes substrate binding at other sites, this is called positive homotropic behavior (one of the allosteric interactions). When this co-operative phenomenon is caused by a compound other than the substrate, the behavior is designated as a positive heterotropic response. Equation (6) explains some of the profile of rate constant vs. detergent concentration. Thus, Piszkiewicz claims that micelle-catalyzed reactions can be conceived as models of allosteric enzymes. A major factor which causes the different kinetic behavior [i.e. (4) vs. (5)] will be the hydrophobic nature of substrate. If a substrate molecule does not perturb the micellar structure extensively, the classical formulation of (4) is derived. On the other hand, the allosteric kinetics of (5) will be found if a hydrophobic substrate molecule can induce micellization. 

The symmetry model (fig. 2.4) of allostery can describe the cooperative binding of substrate to enzyme (homotropic effect), as well as the influence of effector molecules on the activity of enzymes (heterotropic effect). 

Metabolic activators and inhibitors are structurally dissimilar to substrates. These effectors exert regulatory control over catalysis by binding at an allosteric site quite distinct from the catalytic site. Such heterotropic interactions are mediated through conformational changes, often involving subunit interactions. Allosteric effectors can alter the catalytic rate by changing the apparent substrate affinity (K system) or by altering the... 

One of the first known examples of allosteric feedback inhibition was the bacterial enzyme system that catalyzes the conversion of L-threonine to L-isoleucine in five steps (Fig. 6-28). In this system, the first enzyme, threonine dehydratase, is inhibited by isoleucine, the product of the last reaction of the series. This is an example of heterotropic allosteric inhibition. Isoleucine is quite specific as an inhibitor. No other intermediate in this sequence inhibits threonine dehydratase, nor is any other enzyme in the sequence inhibited by isoleucine. Isoleucine binds not to the active site but to another specific site on the enzyme molecule, the regulatory site. This binding is noncovalent and readily reversible if the isoleucine concentration decreases, the rate of threonine dehydration increases. Thus threonine dehydratase activity responds rapidly and reversibly to fluctuations in the cellular concentration of isoleucine. 

For heterotropic allosteric enzymes, those whose modulators are metabolites other than the normal substrate, it is difficult to generalize about the shape of the substrate-saturation curve. An activator may cause the curve to become more nearly hyperbolic, with a decrease in Z0.5 but no change in Fmax, resulting in an increased reaction velocity at a fixed substrate concentration (V0 is higher for any value of [S] Fig. 6-29b, upper curve). 

Other heterotropic allosteric enzymes respond to an activator by an increase in Fmax with little change in if0i5 (Fig. 6-29c). A negative modulator (an inhibitor) may produce a more sigmoid substrate-saturation curve,... 

Fig. 9-10 Behavior of an MWC allosteric enzyme in the presence of positive and negative heterotropic effectors. The activator term, y, in Eq. (9.62) causes the curve to become more hyperbolic, whereas the inhibitor term (j3) renders it more sigmoidal. The curves were constructed using Eq. (9.62) with L = 1,000 and n - 4.

The product of this reaction, oxaloacetate, can either enter the gluconeogenic pathway (Chap. 11) by way of malate or condense with acetyl-CoA to yield citrate. Pyruvate carboxylase is an allosteric enzyme, and it is activated by the heterotropic effector, acetyl-CoA. Thus, pyruvate in the mitochondria is the substrate for either pyruvate dehydrogenase or pyruvate carboxylase, the activities of which, in turn, are controlled by reactants associated with the citric acid cycle. The interplay among pyruvate dehydrogenase, pyruvate carboxylase, pyruvate, and the citric acid cycle is shown in Fig. 12-9. 

According to the concerted model, an allosteric activator shifts the conformational equilibrium of all subunits toward the R state, whereas an allosteric inhibitor shifts it toward the T state. Thus, ATP (an allosteric activator) shifted the equilibrium to the R form, resulting in an absorption change similar to that obtained when substrate is bound. CTP had a different effect. Hence, this allosteric inhibitor shifted the equilibrium to theT form. Thus, the concerted model accounts for the ATP-induced and CTP-induced (heterotropic), as well as for the substrate-induced (homotropic), allosteric interactions of ATGase. 

Many proteins are regulated by molecules which bind somewhere other than at the active site and either inerease or decrease protein activity. These allosteric ejfectors are often quite specific and may have either a positive or negative effect upon protein activity. C ass cdX feedback inhibition cycles in metabolism generally involve heterotropic allostery, in which a molecule produced near the end of a metabolic pathway acts as an allosteric effector to regulate a protein active earlier in the same pathway. Because of the need for very precise control of the energy charge of the cell, ATP and ADP serve as allosteric effectors for several of the proteins of glucose metabolism. Protons and ions act as allosteric effectors in many... 

---